Home » Stocks » TherapeuticsMD

TherapeuticsMD, Inc. (TXMD)

Stock Price: $1.38 USD -0.06 (-4.17%)
Updated Oct 27, 2020 4:00 PM EDT - Market closed
After-hours: $1.39 +0.01 (0.73%) Oct 27, 7:08 PM

Stock Price Chart

Key Info

Market Cap 375.77M
Revenue (ttm) 62.57M
Net Income (ttm) -190.23M
Shares Out 272.29M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $1.38
Previous Close $1.44
Change ($) -0.06
Change (%) -4.17%
Day's Open 1.44
Day's Range 1.38 - 1.44
Day's Volume 1,372,267
52-Week Range 0.85 - 3.20

More Stats

Market Cap 375.77M
Enterprise Value 515.04M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 272.29M
Float 238.06M
EPS (basic) -0.72
EPS (diluted) -0.73
FCF / Share -0.64
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 85.73M
Short Ratio 32.74
Short % of Float 36.01%
Beta 2.02
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 6.01
PB Ratio 40.75
Revenue 62.57M
Operating Income -167.42M
Net Income -190.23M
Free Cash Flow -173.50M
Net Cash -139.27M
Net Cash / Share -0.51
Gross Margin 69.22%
Operating Margin -267.57%
Profit Margin -304.00%
FCF Margin -277.28%
ROA -46.29%
ROE -2,499.18%
ROIC -73.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (8)

Buy 6
Overweight 0
Hold 1
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$6.46*
(368.12% upside)
Low
1.20
Current: $1.38
High
13.00
Target: 6.46
*Average 12-month price target from 7 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue49.6516.1016.7819.3620.1415.038.783.822.091.24
Revenue Growth208.38%-4.04%-13.32%-3.9%34.05%71.23%129.85%82.84%68.14%-
Gross Profit43.3113.3614.1415.1715.6411.356.822.471.140.69
Operating Income-151-130-77.63-90.25-85.19-54.04-25.81-16.15-5.43-2.87
Net Income-176-133-76.93-89.88-85.08-54.22-28.42-35.12-12.91-2.87
Shares Outstanding24622520619617315012891.6362.5238.29
Earnings Per Share-0.72-0.59-0.37-0.46-0.49-0.36-0.22-0.38-0.21-0.07
Operating Cash Flow-166-107-76.16-69.14-79.04-45.52-20.77-12.74-4.97-2.84
Capital Expenditures-2.45-0.22-0.06-0.40-0.17-0.03-0.04-0.07-0.03-0.03
Free Cash Flow-168-107-76.22-69.54-79.21-45.55-20.81-12.80-5.00-2.87
Cash & Equivalents16116212713264.7151.3654.191.550.130.42
Total Debt20473.38-----3.592.35-
Net Cash / Debt-42.9588.2312713264.7151.3654.19-2.04-2.220.42
Assets26621214314273.7359.0862.025.931.441.20
Liabilities25711413.3214.9810.6710.697.327.363.150.23
Book Value9.2097.5213012763.0648.3954.70-1.43-1.710.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TherapeuticsMD, Inc.
Country United States
Employees 348
CEO Robert G. Finizio

Stock Information

Ticker Symbol TXMD
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: TXMD

Description

TherapeuticsMD operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17Ăź-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.